Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG-Fresenius S for GvHD prophylaxis in matched unrelated donor allogeneic stem cell transplantation
DRKS00000002Phase 3Completed
- Sponsor
- Neovii Pharmaceuticals
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 10
01
Overview
A Phase 3 trial of antithymocyte globulin rabbit in leukemia, graft-versus-host disease (GVHD), sponsored by Neovii Pharmaceuticals. Started Aug 2008; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
leukemiagraft-versus-host disease (GVHD)
Beyond the preview
Go deeper on DRKS00000002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000002.